Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
CPIX
CPIX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest CPIX ETF News Today | Earnings, Events & Price Alerts
CPIX News
Cumberland Pharmaceuticals Highlights 2025 Financial and International Progress
14h ago
Newsfilter
Cumberland Pharmaceuticals Q4 2025 Earnings Call Highlights
12h ago
seekingalpha
Cumberland Pharmaceuticals Reports Significant FY Growth
14h ago
seekingalpha
Cumberland (CPIX) Q4 2025 Earnings Call Transcript
14h ago
NASDAQ.COM
Cumberland Pharmaceuticals Highlights 2025 Financial and International Progress
14h ago
PRnewswire
Talicia Full Sales Launch Begins, Unlocking Market Potential
Feb 25 2026
PRnewswire
Cumberland Launches National Sales Promotion for Talicia®
Feb 25 2026
PRnewswire
Cumberland Pharmaceuticals Receives FDA Fast Track Designation
Feb 04 2026
PRnewswire
Cumberland Receives FDA Fast Track Designation for DMD Therapy
Feb 04 2026
Newsfilter
Key Research Insights on NVIDIA, Netflix, and Merck
Dec 19 2025
NASDAQ.COM
Zacks Begins Coverage of CPIX with a Positive Outlook
Dec 19 2025
NASDAQ.COM
Cumberland Pharmaceuticals Launches J-Code for Caldolor Injection, Enhancing Non-Opioid Pain Management
Dec 08 2025
PRnewswire
Cumberland Pharmaceuticals Links Caldolor Injection to J-Code J1741, Enhancing Non-Opioid Pain Management
Dec 08 2025
Newsfilter
Medtech Stocks Surge in After-Hours Trading: RxSight, Penumbra, and Evolus Take the Lead
Nov 06 2025
NASDAQ.COM
Cumberland announces product expansion and reports $8.3M in Q3 revenue while progressing clinical pipeline
Nov 04 2025
SeekingAlpha
CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH
Nov 04 2025
PRnewswire
Show More News
